Equities

Ifa Systems AG

  • Add to watchlist
  • Add to portfolio
  • Add an alert
IS8:HAM

Ifa Systems AG

Actions
  • Price (EUR)2.30
  • Today's Change0.000 / 0.00%
  • Shares traded100.00
  • 1 Year change+4.55%
  • Beta0.5606
Data delayed at least 15 minutes, as of Mar 02 2026 07:16 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Ifa Systems AG is a Germany-based company that provides information technology (IT) solutions and components for eye care specialists. It develops, distributes and installs software, medicine information systems for clinics and medical practitioners, particularly for ophthalmic surgeons, ophthalmologists, technicians, nurses, as well as eye care managers and administrators. The Company’s main product is an electronic patient file, which includes all information about the examination and treatment, based on gathered data from more than 480 ophthalmological devices. It also provides solutions that enable the capture, analysis and archiving of images, documents and data, as well as scheduling and workflow management. In addition, it offers consulting, system integration, training, and hotline services.

  • Revenue in EUR (TTM)5.88m
  • Net income in EUR-570.00k
  • Incorporated2002
  • Employees47.00
  • Location
    Ifa Systems AGAugustinusstr. 11bFRECHEN 50226GermanyDEU
  • Phone+49 2 234933670
  • Fax+49 22 349336730
  • Websitehttps://www.ifasystems.de/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Redsense Medical AB (publ)2.25m-672.32k5.10m4.00--1.59--2.27-0.4345-0.43451.462.080.59281.153.896,005,750.00-17.70-13.95-19.42-15.5064.7867.87-29.85-27.832.93-------14.7410.72-2,197.37---0.1024--
Aton SA-100.00bn-100.00bn5.13m9.00--12.19----------0.0005-----------17.95---27.45-------741.480.3307--0.8386--0.326821.1886.01------
SpectraCure AB (publ)133.30k-4.98m5.18m13.00--0.3971--38.83-0.165-0.1650.00520.24680.012--1.90109,384.60-44.68-13.14-49.10-14.07835.02243.69-3,739.03-592.49---197.290.0325---46.15-13.97-12.54--0.1962--
Bio-Gate AG6.98m-1.38m5.18m46.00--5.67--0.7417-0.1522-0.15220.77460.09871.631.8418.31158,615.20-33.43-27.70-46.89-39.9157.7258.42-20.56-20.590.5521-22.330.00---2.6615.13-0.0006---13.98--
ScandiDos AB5.57m-129.46k5.25m25.00--1.3090.740.943-0.0242-0.02421.040.75760.84161.525.602,283,539.00-1.96-8.71-3.04-14.6848.3052.29-2.33-10.670.7927--0.00--2.341.55102.23---11.62--
Inventionmed SA750.82k-307.53k5.38m4.00--100.80--7.16-0.0064-0.00640.01560.00110.082512.904.65792,700.00-3.38-15.98-5.46-23.9091.8386.67-40.96-878.340.15430.1714----1,041.56260.6170.50---29.83--
Cambridge Nutritional Sciences PLC9.20m1.56m5.43m84.003.500.43052.380.59050.00570.00570.03380.04650.61533.593.5795,940.4810.42-3.2211.69-3.6766.4458.8516.94-7.213.79--0.021---14.77-3.23577.44---29.24--
Kontigo Care AB2.73m-194.42k5.45m10.00--1.1516.082.00-0.0589-0.05890.82621.430.4487--7.97---3.190.296-3.980.4064125.51129.99-7.120.4638----0.00---3.667.41-367.61--17.15--
Spineway SA10.99m-1.90m5.69m43.00--0.2383--0.5176-0.0488-0.04880.24510.67130.37390.62053.44224,244.90-6.47-25.14-7.73-30.7671.3376.66-17.29-77.572.04-0.85290.0607--13.6018.9540.63---27.97--
Episurf Medical AB1.51m-5.45m5.74m18.00--1.29--3.80-0.0533-0.05330.01380.02860.2043--4.54894,444.40-72.97-47.42-86.27-52.18-----357.14-701.121.41-579.000.0935--22.9018.1323.42--7.81--
ifa systems AG5.88m-570.00k6.33m47.00--0.91924.611.08-0.2073-0.20732.142.500.557611.876.94125,000.00-5.411.67-6.452.2088.2486.82-9.703.222.37--0.000.0015.46-6.8694.40------
Neola Medical AB0.00-1.03m6.33m8.00--0.8905-----0.1445-0.14450.000.97250.00-------14.46-14.22-15.23-15.24--6,686.88---7,536.325.75-----------9.52------
Carmat SA6.97m-51.40m6.36m153.00------0.9128-1.21-1.210.1566-0.77080.1461.401.4845,549.02-107.63-80.36-152.29-100.51-338.50---737.48-2,088.981.01-15.432.46--149.16--4.59--18.44--
Feedback plc969.82k-8.20m6.88m28.00--1.35--7.09-0.1641-0.16410.01940.10180.0996--8.2530,343.57-84.21-38.54-90.47-41.6584.2390.05-845.25-435.27----0.00---25.0514.50-121.85---1.14--
Proteome Sciences plc5.17m-3.80m7.19m36.00------1.39-0.0113-0.01130.0153-0.02910.50875.925.75125,750.00-37.44-8.02----17.4345.80-73.60-15.070.0774-2.512.26---2.800.9731-39.42--31.03--
BibbInstruments AB37.69k-1.37m7.43m4.00--2.11--197.11-0.3677-0.36770.01020.92380.0109--0.4997100,500.00-39.52-36.87-44.26-40.5416.4217.99-3,634.33-14,348.682.96--------10.72-14.97---0.0892--
Data as of Mar 02 2026. Currency figures normalised to Ifa Systems AG's reporting currency: Euro EUR

Institutional shareholders

9.96%Per cent of shares held by top holders
HolderShares% Held
Discover Capital GmbHas of 31 Oct 2025274.00k9.96%
Data from 31 Oct 2025 - 31 Oct 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.